Targeting cancer stem cells is a therapeutic strategy that holds hope for the improvement of patients’ survival.
Human Protein Atlas | Primary Antibodies | MolBoolean | PrEST Control Antigens | IHC | ICC | WB | ChIP | Enhanced Antibody Validation
Cancer stem cells (CSCs) are a small number of cells, usually 1% to 3% of all cells in a tumor, that drive the tumor’s initiation, growth and metastasis, and may cause relapse. Due to their importance, several biomarkers that characterize CSCs have been identified, allowing diagnostic, therapeutic, and prognostic predictions. Thus, selectively targeting CSCs with various agents holds hope for improvement of cancer patients’ survival and is a promising therapeutic strategy against cancer.
This white paper provides an overview of the most prominent CSC markers, focusing on solid cancers (lung, stomach, liver, breast, and colorectal cancers) and hematological cancers (acute and chronic myeloid leukemias).
Human Protein Atlas | Primary Antibodies | MolBoolean | PrEST Control Antigens | IHC | ICC | WB | ChIP | Enhanced Antibody Validation
We gladly support you by keeping you updated on our latest products and developments
